These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 486686)

  • 1. Prophylaxis and therapy of HBsAg positive hepatitis.
    Weimar W; Schellekens H
    Biomedicine; 1979 Jul; 30(3):135-8. PubMed ID: 486686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for acute and chronic hepatitis.
    Dienstag JL; Isselbacher KJ
    Arch Intern Med; 1981 Oct; 141(11):1419-23. PubMed ID: 7025776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis type virus B.
    Schalm SW
    Hepatogastroenterology; 1984 Feb; 31(1):12-6. PubMed ID: 6199273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children.
    Demirci F; Bayraktaroğlu Z; Karaoğlan M; Coşkun Y; Karaoğlan I; Okan V
    Turk J Gastroenterol; 2005 Dec; 16(4):188-93. PubMed ID: 16547845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of chronic hepatitis (author's transl)].
    Auer IO
    Leber Magen Darm; 1980 Oct; 10(5):251-8. PubMed ID: 6162069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.
    Goudeau A; Lo KJ; Coursaget P; Tong MJ; Yeh CL; Tsai YT; Lee JK; Wu TC; Yeh SH; Lee SD
    Dev Biol Stand; 1983; 54():399-404. PubMed ID: 6228473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and anti-viral therapy of chronic hepatitis B virus infection.
    Thomas HC; Bassendine MF
    Clin Gastroenterol; 1980 Jan; 9(1):85-95. PubMed ID: 6156790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis and treatment of hepatitis B in immunocompromised patients.
    Marzano A; Angelucci E; Andreone P; Brunetto M; Bruno R; Burra P; Caraceni P; Daniele B; Di Marco V; Fabrizi F; Fagiuoli S; Grossi P; Lampertico P; Meliconi R; Mangia A; Puoti M; Raimondo G; Smedile A;
    Dig Liver Dis; 2007 May; 39(5):397-408. PubMed ID: 17382608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive immunoprophylaxis of hepatitis B virus infections in newborn infants.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1985 Oct; 98(788):851-3. PubMed ID: 3864038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic measures after hepatitis B virus infection: postexposure prophylaxis.
    De Groote JJ
    Postgrad Med J; 1987; 63 Suppl 2():33-9. PubMed ID: 3317358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The assessment of efficacy of hepatitis B prophylaxis in children with acute lymphoblastic leukemia].
    Moryl-Bujakowska A; Czogała M; Czogała W; Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():85-8. PubMed ID: 15686054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
    Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
    Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus infection.
    Chang MH
    Semin Fetal Neonatal Med; 2007 Jun; 12(3):160-7. PubMed ID: 17336170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.